healthFDA Approves FluMist as First Self-Administered at-Home Nasal Spray Flu Vaccine
The US FDA has approved AstraZeneca's FluMist Quadrivalent nasal spray as the first self-administered influenza vaccine, enabling Americans to vaccinate against seasonal flu at home without needles.